Plamotamab (XmAb®13676) for Ibrutinib- refractory CXCR4-mutated extramedullary Waldenström macroglobulinemia

Ricardo D. Parrondo, Aneel Paulus, Victoria Alegria, David Liebowitz, Chelsea Johnson, Raphael Clynes, Vivek Roy, David M. Menke, Liuyan Jiang, Asher A. Chanan-Khan, Sikander Ailawadhi

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)738-742
Number of pages5
JournalLeukemia and Lymphoma
Issue number3
StatePublished - 2022

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this